Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation

Abstract

Altered acetylation/deacetylation balance as the result of SIRT1 inactivation is involved in the pathogenesis of PAH, and this enzyme could be a promising therapeutic target for PAH treatment.